What the labels say
The drug-interaction sections of the Wegovy and Zepbound labels cover slower absorption of oral medicines, low blood sugar with insulin or sulfonylureas, and (for Zepbound) oral contraceptives. Neither lists alcohol.[1][2]
Where alcohol matters
- Nausea. The NHS advises that alcohol can make semaglutide's nausea worse.[3]
- Low blood sugar. For people with diabetes on insulin or a sulfonylurea, the labels already warn about hypoglycemia, and alcohol lowers blood sugar too.[1][2]
- Pancreas. Pancreatitis is a listed warning for these drugs, and heavy drinking is a well-known cause of pancreatitis on its own; the labels do not quantify any combined risk.[1][2]
- Dehydration. Alcohol adds to fluid loss in a body that may already be drinking less.[1][2]
Losing interest in drinking
This is one of the most common forum observations, and there is now trial evidence behind it. In a 9-week randomized trial in 48 adults with alcohol use disorder, low-dose semaglutide (up to 1 mg) reduced how much people drank in a lab session, drinks per drinking day and weekly craving, but did not reduce the number of drinking days.[4] It is a small, short trial; semaglutide is not approved for alcohol use disorder.[4]
Heard vs evidence
The short version
Short on the way. A 35-second captioned version of this page is in production for the Fewer Bites channel. It will be embedded here when it is live.
Questions to bring to your prescriber
Print these or screenshot them. They are conversation starters, not a checklist of things to do.
- With my medicines and history, is there a level of drinking you would want me to stay under?
- If I take insulin or a sulfonylurea, what should I know about alcohol and low blood sugar?
- If I have noticed I drink less, or more, should we talk about it?
Education, not advice. This page explains what trials, labels and guidelines report. It does not tell anyone to start, change or stop a medicine. Your prescriber knows your history; this page does not.
Sources
- Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, prescribing information, revised 06/2026. label
- Eli Lilly / FDA. Zepbound (tirzepatide) prescribing information, revised 08/2026. label
- NHS. Semaglutide: side effects and advice. guidance
- Hendershot CS et al. Once-weekly semaglutide in adults with alcohol use disorder: a randomized clinical trial. JAMA Psychiatry 2025. abstract only · RCT · small (n=48)